JENNIFER REEDY: Open Payments
NPI 1427681899 · NICKELSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 63 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $330 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $241 |
| E.R. Squibb & Sons, L.L.C. | 6 | $218 |
| Teva Pharmaceuticals USA, Inc. | 10 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $169 |
| Otsuka America Pharmaceutical, Inc. | 5 | $150 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Alkermes, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $20 |
Products named: VRAYLAR, COBENFY, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, UZEDY, ARISTADA, REXULTI.
Industry payments across VA — which companies pay providers there.
